[go: up one dir, main page]

AU2001289876A1 - Medicament containing activated antithrombin III - Google Patents

Medicament containing activated antithrombin III

Info

Publication number
AU2001289876A1
AU2001289876A1 AU2001289876A AU2001289876A AU2001289876A1 AU 2001289876 A1 AU2001289876 A1 AU 2001289876A1 AU 2001289876 A AU2001289876 A AU 2001289876A AU 2001289876 A AU2001289876 A AU 2001289876A AU 2001289876 A1 AU2001289876 A1 AU 2001289876A1
Authority
AU
Australia
Prior art keywords
antithrombin iii
containing activated
medicament containing
activated antithrombin
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001289876A
Other versions
AU2001289876B2 (en
Inventor
Martin Brodde
Beate Kehrel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hamburger Stiftung zur Forderung von Wissenschaft und Kultur
Original Assignee
Hamburger Stiftung zur Forderung von Wissenschaft und Kultur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10045047A external-priority patent/DE10045047A1/en
Application filed by Hamburger Stiftung zur Forderung von Wissenschaft und Kultur filed Critical Hamburger Stiftung zur Forderung von Wissenschaft und Kultur
Publication of AU2001289876A1 publication Critical patent/AU2001289876A1/en
Assigned to HAMBURGER STIFTUNG ZUR FORDERUNG VON WISSENSCHAFT UND KULTUR reassignment HAMBURGER STIFTUNG ZUR FORDERUNG VON WISSENSCHAFT UND KULTUR Request for Assignment Assignors: Keherel, Beate
Application granted granted Critical
Publication of AU2001289876B2 publication Critical patent/AU2001289876B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001289876A 2000-09-12 2001-09-12 Medicament containing activated antithrombin III Ceased AU2001289876B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10045047.4 2000-09-12
DE10045047A DE10045047A1 (en) 2000-09-12 2000-09-12 Medicament containing activated antithrombin III
PCT/EP2001/010541 WO2002022150A2 (en) 2000-09-12 2001-09-12 Medicament containing activated antithrombin iii

Publications (2)

Publication Number Publication Date
AU2001289876A1 true AU2001289876A1 (en) 2002-06-13
AU2001289876B2 AU2001289876B2 (en) 2006-09-07

Family

ID=7655909

Family Applications (2)

Application Number Title Priority Date Filing Date
AU8987601A Pending AU8987601A (en) 2000-09-12 2001-09-12 Medicament containing activated antithrombin iii
AU2001289876A Ceased AU2001289876B2 (en) 2000-09-12 2001-09-12 Medicament containing activated antithrombin III

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU8987601A Pending AU8987601A (en) 2000-09-12 2001-09-12 Medicament containing activated antithrombin iii

Country Status (14)

Country Link
US (2) US7388075B2 (en)
EP (1) EP1435985B1 (en)
JP (1) JP5517387B2 (en)
AP (1) AP2049A (en)
AT (1) ATE359085T1 (en)
AU (2) AU8987601A (en)
CY (1) CY1106657T1 (en)
DE (2) DE10045047A1 (en)
DK (1) DK1435985T3 (en)
ES (1) ES2283432T3 (en)
NZ (1) NZ525292A (en)
PT (1) PT1435985E (en)
WO (1) WO2002022150A2 (en)
ZA (1) ZA200302907B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10051983A1 (en) * 2000-10-20 2002-06-13 Beate Kehrel Medicaments useful e.g. for preventing thrombosis, inhibiting transplant rejection or treating chronic inflammatory reactions comprises agents inhibiting binding of oxidized proteins to CD36,
PT1328289E (en) * 2000-10-20 2008-12-10 Hamburger Stiftung Zur Foerder Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof
DE10102048A1 (en) * 2001-01-17 2002-07-18 Aventis Behring Gmbh Use of active antithrombin III having endothelial cell proliferation inhibitory activity for combating diseases associated with angiogenesis, e.g. retinopathy, neuropathy, leprosy and cancer
US20090221475A9 (en) * 2002-04-01 2009-09-03 Kazunori Murakami Treatment of lung disorders
CA2523357C (en) * 2003-04-25 2015-07-14 Hamburger Stiftung Zur Foerderung Von Wissenschaft Und Kultur Treatment of hi-virus infections with oxidised blood proteins
WO2008127355A2 (en) * 2006-10-06 2008-10-23 Celtaxsys, Inc. Chemorepulsion of cells
JP2010235447A (en) * 2007-07-30 2010-10-21 Igaku Seibutsugaku Kenkyusho:Kk Inflammatory cytokine inhibitors
DE102011003936A1 (en) 2011-02-10 2012-08-16 Oxprotect Gmbh Use of proteins / peptides that bind to GRP78 (BIP) in laboratory methods for monitoring platelet aggregation inhibitors
CN105263319A (en) 2013-02-13 2016-01-20 法国化学与生物科技实验室 Proteins with modified glycosylation and methods of production thereof
WO2017149391A1 (en) * 2016-03-02 2017-09-08 Laboratoire Francais Du Fractionnement Et Des Biotechnologies The use of antithrombin for coating organs during transplantation
EP4311556A1 (en) * 2022-07-28 2024-01-31 Grifols Worldwide Operations Limited Antithrombin in stroke

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2739050B2 (en) * 1988-01-28 1998-04-08 ヘキスト薬品工業株式会社 Anticoagulant
DE4311580C1 (en) 1993-04-12 1994-08-18 Werner Prof Dr Med Reutter Glycoproteins, process for their preparation and pharmaceutical compositions containing them
JP3820607B2 (en) 1995-11-10 2006-09-13 三菱ウェルファーマ株式会社 Antithrombin-III liquid preparation and storage stabilization method thereof
US6686303B1 (en) * 1998-11-13 2004-02-03 Kimberly-Clark Worldwide, Inc. Bicomponent nonwoven webs containing splittable thermoplastic filaments and a third component
DE19852729A1 (en) * 1998-11-16 2000-05-18 Werner Reutter Recombinant glycoproteins, processes for their preparation, medicaments containing them and their use
EP1027894A3 (en) 1999-01-28 2001-01-24 Aventis Behring Gesellschaft mit beschränkter Haftung Pharmaceutical preparation for the treatment of inflammatory processes
EP1362127B1 (en) 2001-01-26 2007-11-07 The General Hospital Corporation Serpin drugs for treatment of hiv infection and method of use thereof

Similar Documents

Publication Publication Date Title
AU2002218250A1 (en) Medicament dispenser
AU2001269529A1 (en) Medicine comprising dicyanopyridine derivative
AU2002223827A1 (en) Well treatment
AU2002223028A1 (en) Inhaler
AU2002221601A1 (en) Disinfectant
AU2002222853A1 (en) Therapeutic compounds
AU2002242883A1 (en) Medicament dispenser
AU2001274548A1 (en) Syringe
AU2002223562A1 (en) Medicament dispenser
AU2001280598A1 (en) Anti-occlusion catheter
AU2001268750A1 (en) Flushed-seal respirator
AU2002223503A1 (en) Decondenser unit
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2001289876A1 (en) Medicament containing activated antithrombin III
AU8987601A (en) Medicament containing activated antithrombin iii
AU2001232244A1 (en) Drug comprising combination
AU4085201A (en) Pharmaceutical composition
AU2001295815A1 (en) Multiple purpose catheter
AU2001267135A1 (en) Medicaments
AU2002215902A1 (en) Medicament dispenser
AU2001292578A1 (en) Pharmaceutical compounds
AU3586401A (en) Pharmaceutical composition
AU2001278705A1 (en) Pharmaceutical composition
AU2001282541A1 (en) Medicinal compositions